Choline suppresses hepatocellular carcinoma progression by inhibiting autophagy via upregulation of SLC5A7 and p53, and enhances the efficacy of sorafenib in treating HCC. This evidence concerns the gene SLC5A7 and hepatocellular carcinoma.